CONMED Corp — Director's Dealing 2018

Mar 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-03-06

Reporting Person: Berge Terence M (VP Corp. Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-06	Common Stock	M	10000	$19.26	Acquired	30275	Direct
2018-03-06	Common Stock	F	6499	$61.38	Disposed	23776	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-06	Sars (Stock Appreciation Rights)	$19.26	M	10000	Disposed	2020-06-01	Common Stock (10000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.